Gene therapy: A primer for neurosurgeons

Neurosurgery

Volumn 53, Issue 2, 2003, Pages 364-373

  Chiocca, E Antonio ^a   Piepmeier, Joseph M ^b   Rutka, James T ^b   Berger, Mitchel S ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Cerebral ischemia; Gene therapy; Gliomas; Parkinson's disease; Spinal fusion

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALBINDIN; INTERLEUKIN 2; PROTEIN BCL 2; PROTEIN P53; THYMIDINE KINASE;

BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFICACY; GENE THERAPY; GENE TRANSFER; GLIOMA; HUMAN; MORBIDITY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STROKE;

EID: 0042591656     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000073532.05714.2B     Document Type: Review

References (0)